Study of the in vitro activity of amoxicillin/clavulanic acid and other β-lactam antibiotics against Escherichia coli isolated from urine specimens

被引:3
|
作者
Vanhoof, R [1 ]
Carpentier, M [1 ]
Delannoy, P [1 ]
Fagnart, O [1 ]
Lontie, M [1 ]
Mans, I [1 ]
Nyssen, HJ [1 ]
Van Nimmen, L [1 ]
机构
[1] Inst Pasteur, Eenheid Antibiot Onderzoek, B-1180 Brussels, Belgium
关键词
Escherichia coli; antimicrobial susceptibility; urine specimens;
D O I
10.1179/acb.2001.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 205 serial, unduplicated urinary isolates of Escherichia coli was collected from June through August 1998 in 2 community and 3 hospital laboratories. By using the NCCLS broth microdilution technique, their in vitro susceptibility to ampicillin, amoxicillin/clavulanic acid, cefuroxime, cefuroxime axetil, ticarcillin/clavulanic acid and piperacillin/tazobactam was determined. One hundred and twenty isolates were from hospitalised patients, 85 from ambulatory, 129 community acquired and 76 nosocomial. Half of the nosocomial isolates were obtained from naturally produced and half from alternatively produced urine specimens. In general, the highest susceptibility rates, following NCCLS criteria, were found for piperacillin/ tazobactam (93.2%) followed by cefuroxime (92.2%) and amoxicillin/clavulanic acid (82.9%). Ampicillin showed a clear bimodal distribution with a clear peak fur the resistant population. The highest degree of ampicillin resistance was found in nosocomial isolates. Overall, ampicillin showed the lowest degree of susceptibility. Most of the ampicillin resistant isolates remained susceptible to piperacillin/tazobactam, cefuroxime and amoxicillin/clavulanic acid. In general, the community acquired isolates had higher susceptibility rates than the nosocomial isolates.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [21] Penetration and activity of fosfomycin, ciprofloxacin, amoxicillin plus clavulanic acid and cotrimoxazol in Escherichia coli and Pseudomonas aeruginosa biofilms
    Rodriguez-Martinez, J.
    Ballesta, S.
    Pascual, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S145 - S146
  • [22] In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany
    Kresken, Michael
    Wohlfarth, Esther
    Weikel, Chase
    Butler, Deborah
    Pfeifer, Yvonne
    Werner, Guido
    Paul Ehrlich Soc Infection Therapy
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (02) : 418 - 422
  • [23] In Vitro Activity of Nitroxoline against Escherichia coli Urine Isolates from Outpatient Departments in Germany
    Kresken, Michael
    Koerber-Irrgang, Barbara
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 7019 - 7020
  • [24] INVITRO ACTIVITY OF AMOXYCILLIN PLUS CLAVULANIC ACID AND TICARCILLIN PLUS CLAVULANIC ACID COMPARED WITH THAT OF OTHER ANTIBIOTICS AGAINST ANAEROBIC-BACTERIA
    PIERARD, D
    DEMEYER, A
    ROSSEEL, P
    GLUPCZYNSKI, Y
    STRUELENS, MJ
    DELMEE, M
    PATTYN, SR
    VERSCHRAEGEN, G
    MELIN, P
    LAUWERS, S
    ACTA CLINICA BELGICA, 1989, 44 (04): : 228 - 236
  • [25] Synergistic activity and mode of action of flavonoids isolated from smaller galangal and amoxicillin combinations against amoxicillin-resistant Escherichia coli
    Eumkeb, G.
    Siriwong, S.
    Phitaktim, S.
    Rojtinnakorn, N.
    Sakdarat, S.
    JOURNAL OF APPLIED MICROBIOLOGY, 2012, 112 (01) : 55 - 64
  • [26] In vitro Combined Inhibitory Activities of β-Lactam Antibiotics and Clavulanic Acid Against blaKPC-2-Positive Klebsiella pneumoniae
    Peng, Mingjia
    Han, Renru
    Guo, Yan
    Zheng, Yonggui
    Yang, Feifei
    Xu, Xiaogang
    Hu, Fupin
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 361 - 368
  • [27] STUDY ON ANTIMICROBIAL ACTIVITY OF AUGMENTIN (AMOXICILLIN PLUS CLAVULANIC ACID) IN COMPARISON TO OTHER ANTIBACTERIAL DRUGS
    ZUBKOV, MN
    NONIKOV, VE
    GUGUTSIDZE, EN
    SUTORMINA, TM
    MAKAROVA, OV
    ANTIBIOTIKI I KHIMIOTERAPIYA, 1992, 37 (09) : 34 - 36
  • [28] THE ACTIVITY OF TICARCILLIN IN COMBINATION WITH CLAVULANIC ACID AGAINST BACTEROIDES SPECIES - AN INVITRO COMPARISON WITH OTHER ANTIBIOTICS
    DEBARBEYRAC, B
    QUENTIN, C
    BEBEAR, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 35 - 39
  • [29] In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China
    Huang, Na
    Chen, Tao
    Chen, Liqiong
    Zhang, Ying
    Lin, Yishuai
    Zheng, Xiangkuo
    Zhou, Tieli
    Chen, Lijiang
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 2499 - 2507
  • [30] In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK
    Hopkins, Katie L.
    Mushtaq, Shazad
    Richardson, Judith F.
    Doumith, Michel
    de Pinna, Elizabeth
    Cheasty, Tom
    Wain, John
    Livermore, David M.
    Woodford, Neil
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (05) : 431 - 437